These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 5041775)

  • 21. 6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activity.
    Ben-Zvi Z; Mechoulam R; Edery H; Porath G
    Science; 1971 Nov; 174(4012):951-2. PubMed ID: 5001309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism and disposition of delta-9-tetrahydrocannabinol in man.
    Lemberger L; Axelrod J; Kopin IJ
    Pharmacol Rev; 1971 Dec; 23(4):371-80. PubMed ID: 4943951
    [No Abstract]   [Full Text] [Related]  

  • 23. The clinical pharmacology and dynamics of marihuana cigarette smoking.
    Perez-Reyes M; Owens SM; Di Guiseppi S
    J Clin Pharmacol; 1981; 21(S1):201S-207S. PubMed ID: 6271825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.
    Kemp PM; Abukhalaf IK; Manno JE; Manno BR; Alford DD; Abusada GA
    J Anal Toxicol; 1995 Sep; 19(5):285-91. PubMed ID: 7500614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic disposition of nabilone, a cannabinol derivative, in man.
    Rubin A; Lemberger L; Warrick P; Crabtree RE; Sullivan H; Rowe H; Obermeyer BD
    Clin Pharmacol Ther; 1977 Jul; 22(1):85-91. PubMed ID: 872500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of the disposition of 14C-delta 9-tetrahydrocannabinol and 3H-delta 9-tetrahydrocannabinol.
    Siemens AJ; Doyle OL; Pryor GT
    Life Sci; 1979 Apr; 24(14):1261-74. PubMed ID: 470542
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood levels of 3 H- 9 -tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons.
    McMillan DE; Dewey WL; Turk RF; Harris LS; McNeil JH
    Biochem Pharmacol; 1973 Feb; 22(3):383-97. PubMed ID: 4687134
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson E; Halldin MM
    J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans.
    Cooler P; Gregg JM
    South Med J; 1977 Aug; 70(8):951-4. PubMed ID: 329423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-related heart-rate, perceptual, and decisional changes in man following marihuana smoking.
    Schaefer CF; Gunn CG; Dubowski KM
    Percept Mot Skills; 1977 Feb; 44(1):3-16. PubMed ID: 840603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.
    Wall ME; Sadler BM; Brine D; Taylor H; Perez-Reyes M
    Clin Pharmacol Ther; 1983 Sep; 34(3):352-63. PubMed ID: 6309462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood and brain levels of delta1-tetrahydrocannabinol in mice--the effect of 7-hydroxy-delta1-tetrahydrocannabinol.
    Gill EW; Lawrence DK
    Biochem Pharmacol; 1974 Mar; 23(6):1140-3. PubMed ID: 4824912
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular effects of delta-9-tetrahydrocannabinol in man.
    Weiss JL; Watanabe AM; Lemberger L; Tamarkin NR; Cardon PV
    Clin Pharmacol Ther; 1972; 13(5):671-84. PubMed ID: 4559810
    [No Abstract]   [Full Text] [Related]  

  • 36. Delta(9)-tetrahydrocannabinol,, euphoria and intraocular pressure in man.
    Purnell WD; Gregg JM
    Ann Ophthalmol; 1975 Jul; 7(7):921-3. PubMed ID: 1147519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma protein binding of 7-hydroxy- 1-tetrahydrocannabinol: an active 1-tetrahydrocannabinol metabolite.
    Widman M; Nilsson IM; Agurell S; Borg H; Granstrand B
    J Pharm Pharmacol; 1973 Jun; 25(6):453-7. PubMed ID: 4146583
    [No Abstract]   [Full Text] [Related]  

  • 38. Marihuana metabolites in urine of man. III. Unchanged delta-9-tetrahydrocannabinol.
    Hollister LE; Kanter SL; Board RD; Green DE
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):579-84. PubMed ID: 4420916
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration.
    Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.